Does BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Cause Therapeutic product effect incomplete? 89 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 89 reports of Therapeutic product effect incomplete have been filed in association with BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS. This represents 50.6% of all adverse event reports for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS.
89
Reports of Therapeutic product effect incomplete with BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
50.6%
of all BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS reports
0
Deaths
89
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS?
Of the 89 reports, 89 (100.0%) required hospitalization.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS. However, 89 reports have been filed with the FAERS database.
What Other Side Effects Does BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Cause?
Nausea (139)
Anaemia (132)
Headache (132)
Pyrexia (132)
Constipation (128)
Pain (128)
Erythema (127)
Female genital tract fistula (127)
Oral candidiasis (126)
Proctitis (126)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Alternatives Have Lower Therapeutic product effect incomplete Risk?
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BILASTINE
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST\TIMOLOL
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMEKIZUMAB
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMEKIZUMAB-BKZX